(SYNSAM) Synsam - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0016829709
SYNSAM: Lenses, Frames, Sunglasses, Contact Lenses, Hearing Aids
Synsam AB (publ) is a leading optical retail and eye health services provider in the Nordic Region, operating since 1968. The company offers a comprehensive range of products, including prescription lenses, frames, sunglasses, sports eyewear, contact lenses, and hearing aids. Its services encompass eye examinations (both in-person and online), hearing tests, lifestyle subscriptions, and personal style consultations. Synsam AB also operates under multiple brands, such as Profil Optik, Fellepini, Oscar Eide, EyeQ, Jämtö, and Index, across Sweden, Denmark, Norway, Iceland, the Faroe Islands, and Finland. Its distribution channels include owned stores, franchised locations, and e-commerce platforms.
Headquartered in Stockholm, Sweden, Synsam AB has established itself as a key player in the Nordic optical and hearing care market. The companys business model integrates retail operations with healthcare services, providing a one-stop solution for customers vision and hearing needs. Its product portfolio is complemented by subscription services for contact lenses and lifestyle offerings, enhancing customer retention and recurring revenue streams. Synsam ABs multi-brand strategy allows it to cater to diverse customer segments, from budget-conscious consumers to those seeking premium products.
From a financial perspective, Synsam AB is valued at a market capitalization of 6,416.38M SEK, reflecting its significant presence in the Nordic market. The companys price-to-earnings (P/E) ratio of 17.90 indicates a premium valuation, likely driven by its stable cash flows and growth prospects in the healthcare and retail sectors. The price-to-book (P/B) ratio of 2.51 suggests that investors are willing to pay a premium for its assets and brand equity. The return on equity (RoE) of 14.32% highlights efficient profitability relative to shareholder equity.
Technically, Synsam ABs stock (Ticker: SYNSAM) is trading at 45.95 SEK, above its 20-day (42.78) and 50-day (44.60) moving averages, signaling short-term momentum. The 200-day moving average of 45.27 suggests the stock is in a neutral to slightly bullish trend over the longer term. The average true range (ATR) of 1.55 indicates moderate volatility, providing traders with opportunities for intraday and swing strategies. The average volume of 189,134 shares over the past 20 days reflects decent liquidity, supporting active trading interest.
Over the next three months, Synsam ABs stock is expected to trade in a range of 43.50 to 48.50 SEK, influenced by its current momentum and technical indicators. The stock may face resistance near the 48.00 level, while support is likely to hold around 43.50. The 50-day moving average of 44.60 could act as a key inflection point, with a potential breakout above this level signaling further upside.
Fundamentally, Synsam ABs valuation multiples (P/E: 17.90, P/S: 1.00) suggest the market expects continued growth in its optical and hearing care segments. The companys ability to maintain its margins and expand its service offerings will be critical drivers of shareholder value. Any material changes in consumer spending patterns or competitive dynamics in the Nordic region could impact the stocks performance during this period.
Additional Sources for SYNSAM Stock
SYNSAM Stock Overview
| Market Cap in USD | 664m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC Sub-Industry | Life Sciences Tools & Services |
| IPO / Inception |
SYNSAM Stock Ratings
| Growth Rating | -22.2 |
| Fundamental | 71.2 |
| Dividend Rating | 70.5 |
| Rel. Strength | -2.72 |
| Analysts | - |
| Fair Price Momentum | 45.90 SEK |
| Fair Price DCF | 84.56 SEK |
SYNSAM Dividends
| Dividend Yield 12m | 7.75% |
| Yield on Cost 5y | 7.68% |
| Annual Growth 5y | 1.92% |
| Payout Consistency | 98.8% |
SYNSAM Growth Ratios
| Growth Correlation 3m | -65.6% |
| Growth Correlation 12m | -68.4% |
| Growth Correlation 5y | -33.3% |
| CAGR 5y | -0.47% |
| CAGR/Max DD 5y | -0.01 |
| Sharpe Ratio 12m | -0.13 |
| Alpha | -14.04 |
| Beta | 0.454 |
| Volatility | 37.23% |
| Current Volume | 95.5k |
| Average Volume 20d | 190.6k |
As of April 26, 2025, the stock is trading at SEK 46.10 with a total of 95,545 shares traded.
Over the past week, the price has changed by +5.61%, over one month by +1.80%, over three months by -3.14% and over the past year by -2.47%.
Yes, based on ValueRay Fundamental Analyses, Synsam (ST:SYNSAM) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.17 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYNSAM as of April 2025 is 45.90. This means that SYNSAM is currently overvalued and has a potential downside of -0.43%.
Synsam has no consensus analysts rating.
According to ValueRays Forecast Model, SYNSAM Synsam will be worth about 49.6 in April 2026. The stock is currently trading at 46.10. This means that the stock has a potential upside of +7.53%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 66.3 | 43.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.6 | 7.5% |